Economics and Genomics
Yesterday, I spat in a tube, added a preservative solution, and mailed my saliva to 23andMe, a company that provides its customers with some of their genetic data. 23andMe does not sequence whole genomes—that is still extremely expensive. Instead, they examine about 600,000 locations in human DNA, selected on the basis of actual or potential [...]
Tags: 23andMe, adverse selection, genomics, GINA, health insurance, privacy
No Comments »